Clinica Zabala

Facility

Av. Cabildo 1295Buenos Aires C1426AAMArgentina

Location

Av. Cabildo 1295, Buenos Aires, Argentina

Showing 3 of 13 articles found for search query "Clinica Zabala Argentina"

Open-label, controlled, phase 2 clinical trial assessing the safety, efficacy, and pharmacokinetics of INM004 in pediatric patients with Shiga toxin-producing Escherichia coli-associated hemolytic uremic syndrome.
Fayad A, Principi I, Balestracci A, Alconcher L, Coccia P, Adragna M, Amoreo O, Bettendorff MC, Blumetti MV, Bonany P, Tonfi MLF, Flynn L, Ghezzi L, Montero J, Ramírez F, Seminara C, Suarez Á, Spizzirri AP, Rivas M, Pichel M, Zylberman V, Spatz L, Massa C, Valerio M, Sanguineti S, Colonna M, Roubicek I, Goldbaum F, INM004 Study Group
2024
Protective Efficacy of the Epitope-Conjugated Antigen N-Tc52/TSkb20 in Mitigating Trypanosoma cruzi Infection through CD8+ T-Cells and IFNγ Responses.
Vázquez ME, Zabala BA, Mesías AC, Biscari L, Kaufman CD, Alloatti A, Siano F, Picariello G, Corbalán NS, Lenis BA, Toscano MA, Parodi CM, Brandán CMP, Acuña L
2024
Triglyceride Lowering with Pemafibrate to Reduce Cardiovascular Risk.
Das Pradhan A, Glynn RJ, Fruchart JC, MacFadyen JG, Zaharris ES, Everett BM, Campbell SE, Oshima R, Amarenco P, Blom DJ, Brinton EA, Eckel RH, Elam MB, Felicio JS, Ginsberg HN, Goudev A, Ishibashi S, Joseph J, Kodama T, Koenig W, Leiter LA, Lorenzatti AJ, Mankovsky B, Marx N, Nordestgaard BG, Páll D, Ray KK, Santos RD, Soran H, Susekov A, Tendera M, Yokote K, Paynter NP, Buring JE, Libby P, Ridker PM, PROMINENT Investigators
2022

Loading articles